2009年9月30日 星期三
this is an exciting project for a leading
We are extremely pleased to be working with our first Japanese partner,” commented SynCo’s CEO, Mr. Pierre Warffemius, “this is an exciting project for a leading Japanese business and I look forward to the successful completion of R&SGMP manufacture, in the field of live biotherapeutics. This contract represents SynCo’s entryAMSTERDAM - SynCo Bio Partners B.V., the expert in long term GMP contract manufacturing of biopharmaceuticals announced today that it hasPCB QUICK WASH expanded its business into a new geographical market, with the USB connectorsigning of a contract to manufacture a live biotherapeutic for an emerging Japanese pharmaceutical company.The undisclosed company’s product is an innovative live machining centerbiotherapeutic based anticancer drug. The project will first involve a consultancy into the growing Japanese biotherapeutics market and is reflective of our continuing success in a very competitive GMP contract manufacturing market.”phase, during which SynCo will assist the client with in-house process development. The developed process hand dryerwill then be transferred to SynCo’s Amsterdam facility and scaled-up, prior to RF PCBGMP manufacture for Phase I clinical trials, including fermentation, formulation and aseptic filling.“
訂閱:
張貼留言 (Atom)
沒有留言:
張貼留言